The forecasted neoplasms mortality rate in the UK shows a continuous declining trend from 2024 to 2028, starting at 257.5 units in 2024 and decreasing to 245.7 units by 2028. This trend represents a year-on-year percentage decline of around 1.2% on average. In 2023, the rate was 260.3 units, thus the year-on-year variation from 2023 to 2024 is a decrease of approximately 1.1%. Over the last two years combined, the mortality rate fell by approximately 2.2%. Considering a broader five-year perspective, the compound annual growth rate (CAGR) indicates an average reduction of nearly 1.2% per year.
Future trends to watch include advances in cancer treatment and early detection, which could further reduce mortality rates. Additionally, public health initiatives aimed at reducing risk factors such as smoking and obesity may play a significant role in this downward trend. Increased investment in medical research and healthcare infrastructure will also be pivotal in shaping future mortality rates related to neoplasms.
